Stonepine Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Stonepine Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$4.85M	Buy
2025 Q1	$186K	Sell
2024 Q4	$4.04M	Buy
2024 Q3	$3.03M	Buy
2024 Q2	$81.3K	Buy
2018 Q3	–	Sell
2018 Q2	$2.98M	Buy